Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-21
Closed -$1.42K 345
2025
Q3
$1.42K Hold
21
﹤0.01% 380
2025
Q2
$1.37K Hold
21
﹤0.01% 392
2025
Q1
$1.3K Sell
21
-111
-84% -$7.35K ﹤0.01% 349
2024
Q4
$9.52K Hold
132
﹤0.01% 214
2024
Q3
$10.8K Hold
132
﹤0.01% 216
2024
Q2
$9.8K Hold
132
﹤0.01% 218
2024
Q1
$10.3K Buy
132
+1
+0.8% +$74 ﹤0.01% 202
2023
Q4
$9.36K Hold
131
﹤0.01% 206
2023
Q3
$9.09K Hold
131
﹤0.01% 216
2023
Q2
$10.6K Hold
131
﹤0.01% 205
2023
Q1
$10.6K Hold
131
﹤0.01% 210
2022
Q4
$9.8K Buy
+131
New +$9.33K ﹤0.01% 198

Other funds holding HOLX

Trifecta Capital Advisors's HOLX Position: Q4 2025 in Review

Trifecta Capital Advisors sold out of Hologic (HOLX) in Q4 2025, closing a stake of 21 shares — an estimated $1.42K sold.

Trifecta Capital Advisors first reported a position in HOLX in Q4 2022 and held it in 12 quarters. The position peaked at $10.8K in Q3 2024. 749 funds tracked by Wall St. Rank hold HOLX as of Q4 2025.

  • Trifecta Capital Advisors reported no remaining Hologic position as of Q4 2025 after selling out during the quarter.
  • Trifecta Capital Advisors sold 21 Hologic shares in Q4 2025, an estimated $1.42K.
  • Trifecta Capital Advisors first reported a position in Hologic in Q4 2022 and held it in 12 quarters.
  • Trifecta Capital Advisors's Hologic position peaked at $10.8K in Q3 2024.
  • 749 funds tracked by Wall St. Rank held Hologic as of Q4 2025.

Based on Trifecta Capital Advisors's 13F filing for Q4 2025, filed 30 Jan 2026.